Table 1.
Patient Laboratory Data
| 10/15/2010a | 4/28/2011 | 9/3/2011 | 10/6/2011 | 1/12/2012 | 3/10/2012 | 5/10/2012 | 5/16/2012 | 5/23/2012 | 6/6/2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Protein (g/dL) | 7.9 | 7.9 | 8.1 | 7.5 | 7.4 | 7.9 | ||||
| Albumin (g/dL) | 4.2 | 4.4 | 4.3 | 4.2 | 4 | 4.1 | ||||
| AST (IU/L) | 26 | 45 | 34 | 63 | 33 | 27 | 290 | 230 | 166 | 155 |
| ALT (IU/L) | 23 | 84 | 37 | 81 | 39 | 35 | 442 | 184 | 184 | 214 |
| Total bilirubin (mg/dL) | 0.4 | 0.6 | 0.2 | 0.2 | ||||||
| Direct bilirubin (mg/dL) | <0.1 | <0.1 | <0.1 | <0.1 | ||||||
| Alkaline phosphatase (IU/L) | 47 | 49 | 46 | 66 | 83 | 93 | 451 | 563 | 569 | 619 |
| CD4 (cells per cubic millimeter) | 381 | 466 | 253 | 291 | 343 | 370 | 395 | |||
| Percent CD4 (%) | 25.4 | 19.4 | 15.8 | 18.2 | 24.5 | 26.4 | 28.2 | |||
| HIV viral load PCR (copies/mL) | 342 | 31498 | 67373 | 160 | TNDb | TND | ||||
| Hepatitis B surface antigen | Nonreactive | Nonreactive | ||||||||
| Hepatitis B surface antibody (mIU/mL) | <1.0 | |||||||||
| Hepatitis B core IgM antibody (mIU/mL) | Nonreactive | Nonreactive | ||||||||
| Hepatitis C virus antibody (mIU/mL) | Nonreactive | Nonreactive | ||||||||
| Hepatitis C virus qualitative assay | Nonreactive | |||||||||
| Anti-nuclear antibody (mIU/mL) | Nonreactive | |||||||||
| Anti-smooth muscle antibody (mIU/mL) | <1:20 | |||||||||
| Serum protein electrophoresis | Normal pattern |
a
Exact dates altered to ensure patient confidentiality.
b
TND: target not detected, threshold <40 copies.